hipockets

Author Archives

DISCUSSION PAGE FOR $APTO

This thread was initiated in order to provide a dedicated page for the members interested in following developing events at Aptose Biosciences. All posts made here should be about it. Other comments about biotech should be posted to the latest general purpose biotech thread, which on the date this is being written is https://www.stockgumshoe.com/2018/02/biotech-discussion-continued/ , […]

THUMBS UP ON COUNTING THUMBS

  I follow SG by subscribing to the emailed comment notifications and use them to collect KSS’ comments for maintaining the Love KSS spreadsheet (more about that later, see the current KSS thread for its URL). I go to a thread online only (usually) when I need to clarify something about a KSS statement. Since […]

PAGING DR. KSS

Merry Christmas and Happy New Year, Doctor. May this and all future years bring you nothing but happiness, health, good fortune, inner peace, and many BioTech stocks that pique your interest! To your many followers that love, admire, and appreciate you: Perhaps a structured procedure for presenting requests for opinions to the Doctor and the […]

TICKED OFF !

Most of us think that comments disparaging each other do not fit well with the discussion of Biotech stocks, expecially when there is a series of replies. We think such posts waste our time, Gumshoe page space, and email boxes. If you have an urge to be angry and want to vent it, first count […]

IRR BIOTECH NOTES IN THE CLOUD

We need a method for retaining and organizing information about the Biotech tickers discussed here in the lofty retreat of the Gumshoe library. DLH and I are considering starting a Google Doc file (or files) for keeping notes about each biotech ticker discussed fior both KSS opinions and others. . My initial thinking (DLH has […]

Medical Devices and Other Interesting (usually BioTech) Stocks

This microblog is for stocks that do not fit neatly in http://www.stockgumshoe.com/2015/04/microblog-biotech-in-a-dr-kss-less-world/ or http://www.stockgumshoe.com/2015/04/microblog-biotech-by-hendrixnuzzles/. To get started, Thomas Kelly mentioned NVIV on the “……by-hendrixnuzzles blog “: “…. The Neuro-Spinal Scaffold is an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord contusion. The Neuro-Spinal Scaffold provides […]

Technical analysis

TECHNICAL ANALYSIS OF THE FINANCIAL MARKETS was mentioned weeks ago by another Irregular as an excellent reference for technical analysis (TA). ( I apologize for not being able to give him credit, but I could not find his name by searching SGS.) I bought the book because of his recommendation and because the book has […]

Recent Author Comments

On Microblog: DISCUSSION PAGE FOR $APTO
7/2/18 $APTO (FP) -- SEC FILING giving more details about FDA lifting the clinical hold on APTO-253: "....a root cause investigation determined that the event resulted from chemistry and manufacturing based issues.......Up to fifteen clinical cente[...]
On Microblog: DISCUSSION PAGE FOR $APTO
6/29/18 $APTO Press release "FDA Lifts Clinical Hold so MYC Inhibitor APTO-253 Can Return to Phase 1b Trial In Patients With Hematologic Cancers" http://phx.corporate-ir.net/phoenix.zhtml?c=116148&p=irol-secText&TEXT=aHR0cDovL2FwaS50ZW5rd2l6YXJk[...]
On Microblog: DISCUSSION PAGE FOR $APTO
$APTO (FP) 6/4/18 SEC form 6K FILING -- Very positive news, but as of noon today it has not affected the share price! http://phx.corporate-ir.net/phoenix.zhtml?c=116148&p=irol-newsArticle&ID=2352950 "APTOSE ANNOUNCES TWO PUBLICATIONS OF PRECLI[...]
On Microblog: DISCUSSION PAGE FOR $APTO
$APTO FP Interesting reading, if one is into technical analysis, from http://alphabetastock.com/2018/06/01/short-term-trade-secrets-aptose-biosciences-inc-nasdaq-apto/ ........"Top Pick for Friday: Aptose Biosciences Inc (NASDAQ: APTO) Aptose Bi[...]
On Microblog: DISCUSSION PAGE FOR $APTO
$APTO (fp) Lulu, good question. Thank you for making me investigate. Obviously, it is good news in that they have a source for funds for how much they need when they need it . I think this financing arrangement was a good deal for $APTO. T[...]
On Microblog: DISCUSSION PAGE FOR $APTO
$APTO (FP) May 31, 2018 --The SEC filing of the above press release is at http://phx.corporate-ir.net/phoenix.zhtml?c=116148&p=irol-SECText&TEXT=aHR0cDovL2FwaS50ZW5rd2l6YXJkLmNvbS9maWxpbmcueG1sP2lwYWdlPTEyMjg2NTQzJkRTRVE9MCZTRVE9MCZTUURFU0M9U0VDVElPTl9FTlR[...]
On Microblog: DISCUSSION PAGE FOR $APTO
$APTO (FP) May 31, 2018 -- APTOSE Enters into US$20 Million Common Share Purchase Agreement with Aspire Capital Fund, LLC [ http://phx.corporate-ir.net/phoenix.zhtml?c=116148&p=irol-newsArticle&ID=2352475 ] The intent to do this was reported earl[...]
On Microblog: DISCUSSION PAGE FOR $APTO
$APTO full position -- From http://www.thewellesleysnews.com/2018/05/29/two-stocks-to-trade-now-aptose-biosciences-inc-apto-corium-international-inc-cori/ " Sell-side analyst recommendations point to a short term price target of $6.98 on the shares[...]
On Microblog: DISCUSSION PAGE FOR $APTO
Long, Full position . . . .[...]
On Microblog: DISCUSSION PAGE FOR $APTO
Link to Acern Sentinment: https://www.accern.com/company/ "Accern was born in late 2013 out of a desire to automate the discovery of early financial news. We wanted to eliminate the manual process of going to multiple news websites to find actionable[...]
On Microblog: DISCUSSION PAGE FOR $APTO
This might be of interest to day traders, which I'm not: "Media headlines about Aptose Biosciences (NASDAQ:APTO) (TSE:APS) have been trending somewhat positive recently, Accern Sentiment reports. Accern rates the sentiment of media coverage by monitori[...]
On Microblog: DISCUSSION PAGE FOR $APTO
$APTO Here's an analysis of today's chart pattern, along with an explanation of typical indicators: https://www.stmvnews.com/signal-watch-wilder-moving-average-is-below-simple-ma-on-shares-of-aptose-bioscns-apto/[...]
On Microblog: DISCUSSION PAGE FOR $APTO
Here's an interesting comparison of $APTO and $FENC from https://ledgergazette.com/2018/05/26/analyzing-aptose-biosciences-apto-and-fennec-pharmaceuticals-fenc.html "...[$FENC] develops product candidates for use in the treatment of cancer in the Uni[...]
On Microblog: DISCUSSION PAGE FOR $APTO
$APTO 5/24/18 FROM https://www.thelincolnianonline.com/2018/05/24/aptose-biosciences-apto-sees-large-volume-increase.html "Zacks Investment Research upgraded Aptose Biosciences from a “hold” rating to a “buy” rating and set a $4.00 price ta[...]
On Microblog: DISCUSSION PAGE FOR $APTO
5/17/18 $APTO Press Release http://phx.corporate-ir.net/phoenix.zhtml?c=116148&p=irol-secText&TEXT=aHR0cDovL2FwaS50ZW5rd2l6YXJkLmNvbS9maWxpbmcueG1sP2lwYWdlPTEyMjYyNTg5JkRTRVE9MiZTRVE9JlNRREVTQz1TRUNUSU9OX0VYSElCSVQmZXhwPSZzdWJzaWQ9NTc%3d "Aptose to[...]
On Microblog: Discussion page for Arch Therapeutics (ARTH)
$ARTH -- JohnM -- Thank you for your excellent post. We all have heard about the "Gummy Bounce" - I think we saw a "JohnM Bounce" today! :) Please keep commenting! :)[...]
On Microblog: Discussion page for Arch Therapeutics (ARTH)
$ARTH Thanks, JohnM, for the links. Your info gave me impetus to search for "ARTH CE Approval". In their 3/12/18 press release, they stated "Arch also expects to file a CE mark in Europe for AC5 in the second half of 2018." They have been saying [...]
On Microblog: DISCUSSION PAGE FOR $APTO
5/14/18 $APTO -- Received a proxy ballot for Apto from TD Ameritrade, to vote on Directors, appointment of an auditor, Approval of unallocated options under the share option plan of the Corporation, and Approval of unallocated awards under the stock incent[...]
On Microblog: DISCUSSION PAGE FOR $APTO
Back in October '17 the price was fluctuating around $1.50-1.60. I felt that that paragraph was very positive - at today's price they have lined about $50 million in financing, if and when needed. (This is a reply to Feddie. I must have clicked o[...]
On Microblog: DISCUSSION PAGE FOR $APTO
May 10, 2018 -- APTO released a 23 page Q1 2018 Financial Report . The pdf file can be downloaded from http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9NjkzOTY0fENoaWxkSUQ9NDA1MjgyfFR5cGU9MQ==&t=1 . I saw nothing, either positive or negativ[...]

This site and Stock Gumshoe publications and authors do not offer individual financial, investment, medical or other advice. Nothing on this site should ever be considered to be personal advice, research or an invitation to buy or sell any securities. We also make mistakes and bad decisions sometimes, and our reasoning or data should be checked against trusted sources before they inform your investing decisions. Choices regarding how to invest your money or otherwise manage your life or finances are yours, we share only our analysis and opinion and all authors or commenters are individually responsible for the words and opinions they share here. Please read our important disclaimers and policies. Stock Gumshoe is supported by subscribers and by sponsors and advertisers. Stock Gumshoe's employee authors will disclose holdings in any stock covered at time of publication and will not trade in any stocks written about for at least three days after publication. Please see below for complete disclosure, disclaimer and policy information.